Measuring Retention in HIV Care: The Elusive Gold Standard

Background:Measuring retention in HIV primary care is complex, as care includes multiple visits scheduled at varying intervals over time. We evaluated 6 commonly used retention measures in predicting viral load (VL) suppression and the correlation among measures. Methods:Clinic-wide patient-level data from 6 academic HIV clinics were used for 12 months preceding implementation of the Centers for Disease Control and Prevention/Health Resources and Services Administration (CDC/HRSA) retention in care intervention. Six retention measures were calculated for each patient based on scheduled primary HIV provider visits: count and dichotomous missed visits, visit adherence, 6-month gap, 4-month visit constancy, and the HRSA HIV/AIDS Bureau (HRSA HAB) retention measure. Spearman correlation coefficients and separate unadjusted logistic regression models compared retention measures with one another and with 12-month VL suppression, respectively. The discriminatory capacity of each measure was assessed with the c-statistic. Results:Among 10,053 patients, 8235 (82%) had 12-month VL measures, with 6304 (77%) achieving suppression (VL <400 copies/mL). All 6 retention measures were significantly associated (P < 0.0001) with VL suppression (odds ratio; 95% CI, c-statistic): missed visit count (0.73; 0.71 to 0.75, 0.67), missed visit dichotomous (3.2; 2.8 to 3.6, 0.62), visit adherence (3.9; 3.5 to 4.3,0.69), gap (3.0; 2.6 to 3.3, 0.61), visit constancy (2.8; 2.5 to 3.0, 0.63), and HRSA HAB (3.8; 3.3 to 4.4, 0.59). Measures incorporating “no-show” visits were highly correlated (Spearman coefficient = 0.83–0.85), as were measures based solely on kept visits (Spearman coefficient = 0.72–0.77). Correlation coefficients were lower across these 2 groups of measures (range = 0.16–0.57). Conclusions:Six retention measures displayed a wide range of correlation with one another, yet each measure had significant association and modest discrimination for VL suppression. These data suggest there is no clear gold standard and that selection of a retention measure may be tailored to context.

[1]  Richard D Moore,et al.  A low-effort, clinic-wide intervention improves attendance for HIV primary care. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[3]  James D. Scott,et al.  Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel , 2012, Annals of Internal Medicine.

[4]  Richard D Moore,et al.  Comparing different measures of retention in outpatient HIV care , 2012, AIDS.

[5]  A. Westfall,et al.  Early Retention in HIV Care and Viral Load Suppression: Implications for a Test and Treat Approach to HIV Prevention , 2012, Journal of acquired immune deficiency syndromes.

[6]  G. Marks,et al.  The spectrum of engagement in HIV care: do more than 19% of HIV-infected persons in the US have undetectable viral load? , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Richard D Moore,et al.  Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Carlos Del Rio,et al.  The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  B. Branson,et al.  Vital signs: HIV prevention through care and treatment--United States. , 2011, MMWR. Morbidity and mortality weekly report.

[10]  G. Marks,et al.  Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis , 2010, AIDS.

[11]  Christa R. Nevin,et al.  From access to engagement: measuring retention in outpatient HIV clinical care. , 2010, AIDS patient care and STDs.

[12]  E. Vittinghoff,et al.  Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco , 2010, PloS one.

[13]  B. Agins,et al.  Retaining HIV-infected patients in care: Where are we? Where do we go from here? , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  A. Fauci,et al.  Universal voluntary testing and treatment for prevention of HIV transmission. , 2009, JAMA.

[15]  A. Westfall,et al.  Missed visits and mortality among patients establishing initial outpatient HIV treatment. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  V. Stone,et al.  Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Shari Messinger,et al.  HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  H. Cabral,et al.  Outreach program contacts: do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? , 2007, AIDS patient care and STDs.

[19]  M. Suarez‐Almazor,et al.  Retention in care: a challenge to survival with HIV infection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  P. G. Choe,et al.  One‐year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients , 2007, Journal of internal medicine.

[21]  M. Suarez‐Almazor,et al.  The population effectiveness of highly active antiretroviral therapy: Are good drugs good enough? , 2005, Current HIV/AIDS reports.

[22]  R. Frankowski,et al.  Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure , 2005, AIDS care.

[23]  C. Kiefe,et al.  Patient compliance and medical research , 1994, Journal of general internal medicine.